Skip to Content

A-17.5 mg A-17.5 mg (Soriatane 17.5 mg)

Generic Name: acitretin

Pill imprint A-17.5 mg A-17.5 mg has been identified as Soriatane 17.5 mg.

Soriatane is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Soriatane 17.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Soriatane 17.5 mg A-17.5 mg A-17.5 mg
Soriatane 17.5 mg A-17.5 mg A-17.5 mg
Discount Card Promo
Soriatane
Generic Name:
acitretin
Imprint:
A-17.5 mg A-17.5 mg
Strength:
17.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antipsoriatics
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00145-3817
Inactive Ingredients:
microcrystalline cellulose
sodium ascorbate
gelatin
maltodextrin
ferric oxide yellow
ferrosoferric oxide
ferric oxide red
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide